Annual report pursuant to Section 13 and 15(d)

Segment Disclosures

v3.10.0.1
Segment Disclosures
 12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Segment Disclosures
Segment Disclosures

The Company has two reportable segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and sells exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods.

The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.

Segment reporting information is as follows:
 
EksoHealth
 
EksoWorks
 
Other
 
Total
Year ended December 31, 2018
 
 
 
 
 
 
 
Revenue
$
8,826

 
$
2,478

 
$
28

 
$
11,332

Cost of revenue
4,932

 
2,055

 
36

 
7,023

Gross profit
$
3,894

 
$
423

 
$
(8
)
 
$
4,309

 
 
 
 
 
 
 
 
Year ended December 31, 2017
 
 
 
 
 
 
 
Revenue
$
5,831

 
$
1,484

 
$
38

 
$
7,353

Cost of revenue
4,164

 
1,106

 
14

 
5,284

Gross profit
$
1,667

 
$
378

 
$
24

 
$
2,069



Geographic revenue information based on location of customer is as follows:

 
Years Ended December 31
 
2018
 
2017
United States
$
7,028

 
$
4,958

All Other
4,304

 
2,395

 
$
11,332

 
$
7,353